Trial intelligence / Profile preview

Weekly antibiotic cycling for prevention of urinary tract infections in neurogenic bladder

2010-021241-44Phase 4Completed

Sponsor
CHRU Tours
Start
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of amoxicillin + clavulanate, fosfomycin and trimethoprim + sulfamethoxazole in urinary tract infection (UTI) (2 arms), sponsored by CHRU Tours. Primary endpoint: Number of urinary tract infections over 6 months. Started Oct 2010; status: completed.

02

Drugs

amoxicillin + clavulanatefosfomycintrimethoprim + sulfamethoxazole
03

Conditions

urinary tract infection (UTI)

Beyond the preview

Go deeper on 2010-021241-44.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021241-44.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call